Belgian energy report urges review of nuclear phase-out

30 November 2006


The preliminary study, ‘Belgium’s Energy Challenges towards 2030’ concludes that the substantial change in circumstances since the nuclear phase out law was passed “requires a paradigm shift of the current official Belgian standpoint on nuclear power.” Along with a major reconsideration of the current nuclear phase-out policy increased use of renewables and energy diversity and efficiency is also advocated in the report.

The study concludes that to maintain the current policy of phasing out nuclear energy by 2025 would effectively undermine the Belgian economy and significantly increase carbon emissions, “Therefore, Belgium is advised to keep the nuclear option open and should reconsider the nuclear phase out,” the study says.

The report also adds that upon lifting the nuclear phase-out law, an agreement with the owners of the Belgian nuclear power plants should be reached, for stimulating investments in energy savings and demand-side management, developments in renewable energy, and for development and research in emerging energy technologies and carriers.

Santiago San Antonio director general of Foratom, the European trade association for the nuclear energy industry, said: “The results of this Belgian study reflect how a new spirit of pragmatism among European policy-makers is fuelling the use of all sources of energy, especially the low CO2-emitting ones, and the nuclear revival.”

Following further review by government and independent panels the final report is due in June 2007.




Linkedin Linkedin   
Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.